Investing Center Preview – Manage your investments and watch your net worth grow.
ABVC:NASDAQ – Small Cap Stock (Biotechnology)
ABVC Biopharma Inc – ABVC Stock Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|---|---|---|
1.02 | -0.08 (-7.69%) | 0.40 - 1.73 | 228.1 thousand |
Market data as of 12:51PM 04/03/25. Quotes are delayed by at least 15 min.
Overview - ABVC
Open | 1.10 |
---|---|
Previous Close | 1.11 |
Day's Range | 1.02 - 1.17 |
Market Cap | 13.2M |
Avg Volume (10 Day) | 468.6K |
Price/Earnings (Trailing 12 Mo.) | -- |
Earnings Per Share (Trailing 12 Mo.) | -1.772 |
Dividend Yield | No Dividend |
One-Click Scorecard - ABVC


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Performed well consistently? | Fail |
---|---|
Avoids excess debt? | Fail |
Converting sales to profits? | Fail |
Shareholder's money handled rationally? | Neutral |
Increased shareholder value? | Neutral |
Consistently increased owner earnings? | Fail |
Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Pays a cash dividend? | Neutral |
---|---|
Room to increase dividends? | Fail |
Increased earnings over time? | Neutral |
Borrows within reasonable limits? | Pass |
Stock is undervalued? | Fail |
Have investors caught on? | Fail |
Has support of institutional investors? | Fail |
Has sufficient liquidity? | Pass |
Latest Headlines - ABVC
No news headlines available for ABVC
Industry Position - ABVC
ABVC | Industry Range | |
---|---|---|
Revenue Growth (1yr) | -84.28% | |
Net Income Growth (1yr) | -- | |
Total Debt/Equity | 0.28 | |
LT Debt/Equity | 0.02 | |
Earnings Yield | -- | |
Price/Sales | 26.00 |
Competitors - ABVC
Company | Last | Change |
---|---|---|
Mural Oncology PLC | 1.27 | -3.81% |
0.01 | 0.00% | |
Lisata Therapeutics Inc | 2.11 | +1.81% |
0.02 | +15.38% | |
CEL-SCI Corp | 0.19 | -9.60% |
Data is delayed by at least 15 min.